# Why food intake is a separate endpoint from growth hormone

- Article ID: research-078
- Product: CJC-1295 (No DAC) / GHRP-2 (cjc-1295-ghrp-2-674)
- Canonical page: https://heritagebiolabs.com/research-library/articles/078-why-food-intake-is-a-separate-endpoint-from-growth-hormone
- Product collection: https://heritagebiolabs.com/research-library/products/cjc-1295-no-dac-ghrp-2
- Product page: https://heritagebiolabs.com/product/cjc-1295-ghrp-2-674
- Reading focus: Interpreting evidence (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2005, 2024

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides consist of short amino-acid chains linked by peptide bonds. Some signal through receptors that affect several processes, including hormone release and eating behavior. CJC-1295 (No DAC) / GHRP-2 describes a pairing of a modified growth hormone–releasing hormone analogue with GHRP-2, also known as pralmorelin. Could a short growth hormone experiment by itself explain what happens to eating behavior? [1, 2]

An older placebo-controlled human study examined GHRP-2 as a single compound in healthy men. Investigators measured how much food participants ate when offered a meal after the experimental exposure. The men ate more during the GHRP-2 condition than during the placebo condition. Growth hormone was measured separately and also increased. The investigators used the comparison to study whether a synthetic peptide could reproduce an aspect of the response associated with ghrelin, a natural hormone involved in feeding. [2]

The two measurements answer different questions. A change in growth hormone describes an endocrine response, while food consumed at a meal describes a behavior during the observation period. An increase in both does not show that one caused the other. A meal experiment can also leave longer-term eating patterns, body weight, and other metabolic outcomes unmeasured. [2]

No recent primary study testing food intake after exposure to the exact catalog pair was identified. The 2005 result concerns GHRP-2 alone in a particular controlled setting. It leaves open whether the addition of the no-DAC analogue would alter meal intake, change the GH response, affect both or affect neither. This distinction is important when an article describes a pairing using only data from one constituent. [1, 2]

## Sources

1. U.S. Food and Drug Administration. December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting. FDA briefing document on CJC-1295-related bulk drug substances (publication 2024-12-04). <https://www.fda.gov/media/183819/download>
2. Laferrère B et al. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. Journal of Clinical Endocrinology & Metabolism (publication 2005-02). <https://pubmed.ncbi.nlm.nih.gov/15699539/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 016 - CJC-1295 (No DAC) GHRP-2 and CJC-1295 (No DAC) GHRP-6.docx; article 78; content SHA-256 8a68300a2d3d6c06d647c62b22c9d881bc7af2f5152977cd380eec5971950985.
